Your browser doesn't support javascript.
loading
EGFR and mTOR as therapeutic targets in glioblastoma.
Ronellenfitsch, Michael W; Luger, Anna-Luisa; Steinbach, Joachim P.
Afiliação
  • Ronellenfitsch MW; Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; University Cancer Center Frankfurt, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; German Cancer Consortium, Partner Site Frankfurt/Mainz, Frankfurt am Main, Germany; Frankfurt Cancer Institute, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Luger AL; Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; University Cancer Center Frankfurt, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; German Cancer Consortium, Partner Site Frankfurt/Mainz, Frankfurt am Main, Germany; Frankfurt Cancer Institute, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Steinbach JP; Dr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; University Cancer Center Frankfurt, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; German Cancer Consortium, Partner Site Frankfurt/Mainz, Frankfurt am Main, Germany; Frankfurt Cancer Institute, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Oncotarget ; 10(46): 4721-4723, 2019 Jul 30.
Article em En | MEDLINE | ID: mdl-31413813

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha